Skip to main content

Advertisement

SpringerLink
Log in

Role of human papillomavirus in the development of urothelial carcinoma

  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

It has been estimated that almost 10% of the worldwide cancer burden is linked to human papillomavirus (HPV) infection. Although the association between HPV and bladder carcinoma has been extensively investigated, data on the role of HPV in bladder carcinogenesis are controversial. The aim of the study was to assess the possible role of human papillomavirus in the development of urothelial bladder carcinomas. Formalin-fixed and paraffin-embedded archival tissue samples were used for DNA extraction. Seventy urothelial bladder carcinoma tissues were screened by nested-polymerase chain reaction (PCR) for HPV DNA with a control group of total 18 cervical tissues with invasive cervical carcinoma and cervical intraepithelial neoplasia III (CIN III). In the study group, we did not find HPV DNA positivity in any of the urothelial carcinomas. In the control group, 15 out of 18 (83.3%) samples were positive for the HPV DNA. These results indicated that there was no association between HPV infection and urothelial carcinomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Lehoux M, D’Abramo CM, Archambault J. Molecular mechanisms of human papillomavirus-induced carcinogenesis. Public Health Genomics. 2009;12(5–6):268–80.

    Article  PubMed  Google Scholar 

  2. Javier RT, Butel JS. The history of tumor virology. Cancer Res. 2008;68(19):7693–706.

    Article  PubMed  CAS  Google Scholar 

  3. zur Hause H. Papillomaviruses in the causation of human cancers—a brief historical account. Virology. 2009;384(2):260–5.

    Article  Google Scholar 

  4. McLaughlin-Drubin ME, Münger K. Oncogenic activities of human papillomaviruses. Virus Res. 2009;143:195–208.

    Article  PubMed  CAS  Google Scholar 

  5. Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine 24S3 2006;S3/11–S3/25.

  6. Hemminki K, Jiang Y, Dong C. Second primary cancers after anogenital, skin, oral, esophageal and rectal cancers: etiological links? Int J Cancer. 2001;93:294–8.

    Article  PubMed  CAS  Google Scholar 

  7. Hoory T, Monie A, Grawitt P, Wu TC. Molecular epidemiology of human papillomavirus. J Formos Med Assoc. 2008;107(3):198–217.

    Article  PubMed  Google Scholar 

  8. Gasperov NM, Sabol I, Matovina M, Spaventi S, Grce M. Detection and typing of human papillomaviruses combining different methods: polymerase chain reaction, restriction fragment length polymorphism, line probe assay and sequencing. Pathol Oncol Res. 2008;14:355–63.

    Article  Google Scholar 

  9. Buitrago-Perez A, Garaulet G, Vazquez-Carballo A, Paramio JM, Garcia-Escudero R. Molecular signature of HPV-Induced carcinogenesis: pRb, p53 and gene expression profiling. Curr Genomics. 2009;10:26–34.

    Article  PubMed  CAS  Google Scholar 

  10. de Oliveira DE. DNA viruses in human cancer: an integrated overview on fundamental mechanisms of viral carcinogenesis. Cancer Lett. 2007;247:182–96.

    Article  Google Scholar 

  11. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.

    Article  PubMed  Google Scholar 

  12. Fioriti D, et al. Urothelial bladder carcinoma and viral infections: different association with human polyomaviruses and papillomaviruses. Int J Immunopathol Pharmacol. 2003;16(3):283–8.

    PubMed  CAS  Google Scholar 

  13. Aynaud O, Tranbaloc P, Orth G. Lack of evidence for a role of human papillomaviruses in transitional cell carcinoma of the bladder. J Urol. 1998;156(1):86–90.

    Article  Google Scholar 

  14. Lu QL, Lalani EN, Abel P. Human papillomavirus 16 and 18 infection is absent in urinary bladder carcinomas. Eur Urol. 1997;31(4):428–32.

    PubMed  CAS  Google Scholar 

  15. Sano T, Sakurai S, Fukuda T, Nakajima T. Unsuccessful effort to detect human papillomavirus DNA in urinary bladder cancers by polymerase chain reaction and in situ hybridization. Pathol Int. 1995;45(7):506–12.

    Article  PubMed  CAS  Google Scholar 

  16. Youshya S et al. Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis. J Clin Pathol. 2005;58:207–10.

    Article  Google Scholar 

  17. Sur M, Cooper K, Allard U. Investigation of human papillomavirus in transitional cell carcinomas of urinary bladder in South Africa. Pathology. 2001;33(1):17–20.

    PubMed  CAS  Google Scholar 

  18. Helal TEA, Fadel MT, El-Sayed NK. Human papilloma virus and p53 expression in bladder cancer in Egypt: relationship to schistosomiasis and clinicopathologic factors. Pathol Oncol Res. 2006;12(3):173–8.

    Article  Google Scholar 

  19. Noel JC, et al. Transitional cell carcinoma of the bladder: evaluation of the role of human papillomaviruses. Urology. 1994;44(5):671–5.

    Article  PubMed  CAS  Google Scholar 

  20. Lopez-Beltran A, Munoz E. Transitional cell carcinoma of the bladder: low incidence of human papillomavirus DNA detected by polymerase chain reaction and in situ hybridization. Histopathology. 1995;26(6):565–9.

    Article  PubMed  CAS  Google Scholar 

  21. Furihata M, et al. High-risk papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res. 1993;53:4823–7.

    PubMed  CAS  Google Scholar 

  22. Barghi MR, Hajimohammadmehdiarbab A, Hosseini Moghaddam SMM, Kazemi B. Correlation between human papillomavirus infection and bladder transitional cell carcinoma. BMC Infect Dis. 2005;5:102. doi:10.1186/1471-2334-5-102.

    Article  PubMed  CAS  Google Scholar 

  23. Badawi H, et al. Role of human papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder cancer among Egyptian patients. Medscape J Med. 2008;10(10):232–42.

    PubMed  Google Scholar 

  24. Tekin MI et al. Human papillomavirus associated with bladder carcinoma? Analysis by polymerase chain reaction. Int J Urol. 1999;6:184–6.

    Article  Google Scholar 

  25. Agliano AM, et al. High frequency of human papillomavirus detection in urinary bladder cancer. Urol Int. 1994;53(3):125–9.

    Article  PubMed  CAS  Google Scholar 

  26. Anwar K, Naiki H, Nakakuki K, Inuzuka M. High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer. 1992;70(7):1967–73.

    Article  PubMed  CAS  Google Scholar 

  27. Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors. World Health Organization Classification of tumors. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. Lyon: IARC Press; 2004. p. 90–110.

    Google Scholar 

  28. Bozdayi G, Biri A, Rota S. The rapid detection and genotyping of human papillomavirus in genital biopsy specimens by PCR in microbiology laboratory-preliminary study. Turkiye Klinikleri J Gynecol Obst. 2002;12(6):463–5.

    Google Scholar 

  29. Husnjak K, Grce M, Magdic L, Pavelic K. Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical specimens. J Virol Methods. 2000;88:125–34.

    Article  PubMed  CAS  Google Scholar 

  30. Hobbs CGL, Birchall MA. Human papillomavirus infection in the etiology of laryngeal carcinoma. Curr Opin Otolaryngol Head Neck Surg. 2004;12:88–92.

    Article  PubMed  Google Scholar 

  31. Khaled HM, Bahnassi AA, Zekri ARN, Kassem HA, Mokhtar N. Correlation between p53 mutations and HPV in bilharzial bladder cancer. Urol Oncol. 2003;21:334–41.

    Article  PubMed  CAS  Google Scholar 

  32. Aggarwal S, Arora VK, Gupta S, Singh N, Bhatia A. Koilocytosis: correlations with high-risk HPV and its comparison on tissue sections and cytology, urothelial carcinoma. Diagn Cytopathol. 2009;37(3):174–7.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Dr. Sibel Sensu for her assistance with preparation of the manuscript. We also thank Reyhan Haliloglu for the technical assistance.

Conflict of interest statement

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Pathology, Dr. Lutfi Kirdar Kartal Training and Research Hospital, 34865, Cevizli-Istanbul, Turkey

    Dilek Yavuzer, Nimet Karadayi & Dilek Sakirahmet

  2. Department of Medical Oncology, Dr. Lutfi Kirdar Kartal Training and Research Hospital, 34865, Cevizli-Istanbul, Turkey

    Taflan Salepci & Ahmet Bilici

  3. Department of Pathology, Gulhane Medical Academy, Haydarpasa Training Hospital, 34668, Kadikoy-Istanbul, Turkey

    Huseyin Baloglu

Authors
  1. Dilek Yavuzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nimet Karadayi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Taflan Salepci
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Huseyin Baloglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ahmet Bilici
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dilek Sakirahmet
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dilek Yavuzer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yavuzer, D., Karadayi, N., Salepci, T. et al. Role of human papillomavirus in the development of urothelial carcinoma. Med Oncol 28, 919–923 (2011). https://doi.org/10.1007/s12032-010-9540-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-010-9540-1

Keywords

Search

Navigation